VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 139 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $144,255 | -73.5% | 21,890 | -23.5% | 0.04% | -76.3% |
| Q2 2018 | $545,000 | +40.1% | 28,611 | +23.9% | 0.17% | +84.0% |
| Q1 2018 | $389,000 | -44.1% | 23,095 | -40.6% | 0.09% | -52.3% |
| Q3 2017 | $696,000 | +161.7% | 38,900 | +104.7% | 0.20% | +80.7% |
| Q1 2017 | $266,000 | – | 19,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |